Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Drugmakers cling to dual IL-13/IL-4 blockbuster hopes. Nat Biotechnol 36, 3–5 (2018). https://doi.org/10.1038/nbt0118-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0118-3
- Springer Nature America, Inc.
This article is cited by
-
Combination of TLR agonist and miR146a mimics attenuates ovalbumin-induced asthma
Molecular Medicine (2020)
-
Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity
Scientific Reports (2019)